THE BEST SIDE OF CLINICAL INNOVATION

Vascular thrombosis, a essential medical concern, involves prompt removal of blood clots to revive blood flow. A typical intervention technique is intravenous infusion of tissue plasminogen activator (tPA), but its small 50 %-lifetime and susceptibility to inactivation by inhibitors pose problems, bringing about higher doses that bring about bleedi